Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Nov 30, 2018
It is needless to mention that the tug-of-war between cancer and researchers has been growing stronger and stronger. On one side, cancer has positioned itself as a leading cause of death and on the other side, scientists have been working diligently to find out more effective cancer treatments. According to the Amer...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
-Agonist.png "Toll-like Receptors Agonist")
Newsletter/Whitepaper